Find a Clinical Trial
Filter
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast cancer
All genders
18+
Recruiting now
Cancer Center
CKD Registry
Chronic kidney disease
All genders
18-100
Recruiting now
Department of Medicine, Division of Nephrology
Cognitive Impairment in HD patients
Hemodialysis access
All genders
18+
Recruiting now
Department of Medicine, Division of Nephrology
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Breast cancer
All genders
16+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
HER2 Negative Breast Cancer
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Patient participation to donate blood for laboratory analysis
Nephropathy
All genders
18-75
Recruiting now
Department of Medicine, Division of Nephrology
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
BCL Study
Breast cancer
Female
18+
Recruiting now
Department of Surgery